Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Starr

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Medical Bulletin|April 27, 2018
How to talk about genome editingSandy Starr
Journal of Addictive Behaviors, Therapy & Rehabilitation|September 18, 2015
Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment OrganizationsTodd Molfenter, Carol Sherbeck, Mark Zehner, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 2, 2017
Selective patient and public involvement: The promise and perils of pharmaceutical intervention for autismGinny Russell, Sandy Starr, Chris Elphick, et al.
Implementation Science : IS|May 14, 2013
Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trialTodd Molfenter, Jee-Seon Kim, Andrew Quanbeck, et al.
Substance Abuse Treatment, Prevention, and Policy|April 18, 2015
Implementing buprenorphine in addiction treatment: payer and provider perspectives in OhioTodd Molfenter, Carol Sherbeck, Mark Zehner, et al.
Journal of Addiction Medicine|November 28, 2017
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in OhioTodd Molfenter, Carol Sherbeck, Sandy Starr, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Medical Bulletin|April 27, 2018
How to talk about genome editingSandy Starr
Journal of Addictive Behaviors, Therapy & Rehabilitation|September 18, 2015
Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment OrganizationsTodd Molfenter, Carol Sherbeck, Mark Zehner, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|November 2, 2017
Selective patient and public involvement: The promise and perils of pharmaceutical intervention for autismGinny Russell, Sandy Starr, Chris Elphick, et al.
Implementation Science : IS|May 14, 2013
Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trialTodd Molfenter, Jee-Seon Kim, Andrew Quanbeck, et al.
Substance Abuse Treatment, Prevention, and Policy|April 18, 2015
Implementing buprenorphine in addiction treatment: payer and provider perspectives in OhioTodd Molfenter, Carol Sherbeck, Mark Zehner, et al.
Journal of Addiction Medicine|November 28, 2017
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in OhioTodd Molfenter, Carol Sherbeck, Sandy Starr, et al.
Pageof 1